quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:12:45·139d
SECFiling
Vivos Therapeutics Inc. logo

Vivos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

VVOS· Vivos Therapeutics Inc.
Health Care
Original source

Companies

  • VVOS
    Vivos Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Aug 13UpdateRoth Capital$10.00

Related

  • SEC1d
    Vivos Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC8d
    Vivos Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC8d
    SEC Form 10-K filed by Vivos Therapeutics Inc.
  • PR8d
    Vivos Therapeutics Reports Full Year 2025 Financial Results
  • PR8d
    Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
  • INSIDER13d
    SEC Form 3 filed by new insider V-Co Investors 3 Llc
  • PR16d
    Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
  • SEC20d
    Vivos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022